Milestone Pharmaceuticals (MIST) Earnings Date, Estimates & Call Transcripts $1.16 -0.04 (-2.94%) As of 12:20 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Milestone Pharmaceuticals Earnings Summary Milestone Pharmaceuticals issued Q1 2025 earnings on May 14, 2025, reporting an EPS of -$0.31, which missed the consensus estimate of -$0.19 by $0.12. With a trailing EPS of -$0.68, Milestone Pharmaceuticals' earnings are expected to decrease next year, from ($0.62) to ($1.00) per share. Latest Q1 Earnings DateMay. 14EstimatedConsensus EPS (May. 14) -$0.19 Actual EPS (May. 14) -$0.31 Missed By -$0.12 Q1 2025 Earnings ResourcesQ1 2025 Earnings Report Quarterly Report (10-Q) Press ReleasePowered by Get Milestone Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Milestone Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataMIST Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.MIST Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Milestone Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.11-$0.11-$0.11Q2 20251-$0.11-$0.11-$0.11Q3 20251-$0.11-$0.11-$0.11Q4 20252-$0.11-$0.11-$0.11 FY 2025 6 -$0.44 -$0.44 -$0.44 Q1 20262-$0.23-$0.23-$0.23Q2 20262-$0.20-$0.20-$0.20Q3 20261-$0.22-$0.22-$0.22Q4 20261-$0.20-$0.20-$0.20 Milestone Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025-$0.19-$0.31 -$0.12-$0.31--11/12/2024--$0.18-$0.14+$0.04-$0.14--8/8/2024--$0.19-$0.14+$0.05-$0.14--5/13/2024Q1 2024 -$0.26-$0.21+$0.05-$0.21--3/21/2024Q4 2023 -$0.30-$0.32 -$0.02-$0.32--11/13/2023Q3 2023 -$0.38-$0.35+$0.03-$0.35--8/10/2023Q2 2023 -$0.39-$0.37+$0.02-$0.37-- Milestone Pharmaceuticals Earnings - Frequently Asked Questions When did Milestone Pharmaceuticals announce their last quarterly earnings? Milestone Pharmaceuticals (NASDAQ:MIST) last announced its quarterly earning data on Wednesday, May 14, 2025. Learn more on MIST's earnings history. Did Milestone Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Milestone Pharmaceuticals (NASDAQ:MIST) missed the analysts' consensus estimate of ($0.19) by $0.12 with a reported earnings per share (EPS) of ($0.31). Learn more on analysts' earnings estimate vs. MIST's actual earnings. How much revenue does Milestone Pharmaceuticals generate each year? Milestone Pharmaceuticals (NASDAQ:MIST) has a recorded annual revenue of $1 million. How much profit does Milestone Pharmaceuticals generate each year? Milestone Pharmaceuticals (NASDAQ:MIST) has a recorded net income of -$59.69 million. MIST has generated -$0.68 earnings per share over the last four quarters. What is Milestone Pharmaceuticals's EPS forecast for next year? Milestone Pharmaceuticals's earnings are expected to decrease from ($0.62) per share to ($1.00) per share in the next year. More Earnings Resources from MarketBeat Related Companies Gossamer Bio Earnings Date Aquestive Therapeutics Earnings Date iTeos Therapeutics Earnings Date Cidara Therapeutics Earnings Date 2seventy bio Earnings Date Aurora Cannabis Earnings Date Monopar Therapeutics Earnings Date Lifecore Biomedical Earnings Date Kodiak Sciences Earnings Date Compass Therapeutics Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles D-Wave Pushes Back on Short Seller Case With Strong EarningsAppLovin Surges on Earnings: What's Next for This Tech Standout?Can Shopify Stock Make a Comeback After an Earnings Sell-Off?Rocket Lab: Earnings Miss But Neutron Momentum HoldsWhy Nearly 20 Analysts Raised Meta Price Targets Post-EarningsOXY Stock Rebound Begins Following Solid Earnings BeatMonolithic Power Systems: Will Strong Earnings Spark a Recovery? This page (NASDAQ:MIST) was last updated on 5/14/2025 by MarketBeat.com Staff From Our PartnersWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredTrump Made a Deal. Your Retirement Could Still Be in Danger.America is still barreling toward a financial cliff. This isn't political. It's mathematical. And no trade ...Lear Capital | SponsoredBITCOIN Liquidity pools are the backbone of crypto—and right now, they’re exploding with activity. By providing liqui...Awesomely, LLC | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredSilver Demand Is Soaring-Supply Can't Keep UpSilver demand hit 1.16 billion ounces in 2024-while supply fell short again for the fourth year in a row. I...i2i Marketing Group, LLC | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredA New Wealth Divide Is Forming NowOver the years, my proprietary stock system has identified some of the biggest winners long before Wall Street...InvestorPlace | SponsoredBitcoin Just Broke $100K – Are You Positioned?This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Milestone Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Milestone Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MIST Stock Free MIST Stock Alerts